| Autor: |
Mugo C; Department of Research and Programs, Kenyatta National Hospital, P.O. Box 20723-00202, Nairobi, Kenya. cyrusmugodr@gmail.com.; Department of Epidemiology, University of Washington, Seattle, WA, 98104, USA. cyrusmugodr@gmail.com., Seeh D; Department of Research and Programs, Kenyatta National Hospital, P.O. Box 20723-00202, Nairobi, Kenya., Guthrie B; Department of Global Health, University of Washington, Seattle, WA, 98104, USA.; Department of Epidemiology, University of Washington, Seattle, WA, 98104, USA., Moreno M; School of Medicine and Public Health, University of Wisconsin, Madison, WI, 53705, USA., Kumar M; Department of Psychiatry, University of Nairobi, P.O. Box 19676-00202, Nairobi, Kenya., John-Stewart G; Department of Global Health, University of Washington, Seattle, WA, 98104, USA.; Department of Epidemiology, University of Washington, Seattle, WA, 98104, USA.; Department of Pediatrics, University of Washington, Seattle, WA, 98104, USA.; Department of Medicine, University of Washington, Seattle, WA, 98104, USA., Inwani I; Department of Pediatrics, Kenyatta National Hospital, P.O. Box 20723-00202, Nairobi, Kenya., Ronen K; Department of Global Health, University of Washington, Seattle, WA, 98104, USA. |
| Abstrakt: |
We examined patterns of disclosure among youth living with HIV (YLHIV) in Kenya, and the association between self-disclosure and antiretroviral therapy adherence, stigma, depression, resilience, and social support. Of 96 YLHIV, 78% were female, 33% were ages 14-18, and 40% acquired HIV perinatally. Sixty-three (66%) YLHIV had self-disclosed their HIV status; 67% to family and 43% to non-family members. Older YLHIV were 75% more likely to have self-disclosed than those 14-18 years. Of the 68 either married or ever sexually active, 45 (66%) did not disclose to their partners. Those who had self-disclosed were more likely to report internalized stigma (50% vs. 21%, prevalence ratio [PR] 2.3, 1.1-4.6), experienced stigma (26% vs. 3%, PR 11.0, 1.4-86), and elevated depressive symptoms (57% vs. 30%, PR 1.8, 1.0-3.1). The association with stigma was stronger with self-disclosure to family than non-family. Support should be provided to YLHIV during self-disclosure to mitigate psychosocial harms. |
Full text from SpringerLink